What Alzheimer’s Medications Actually Do: A Realistic Guide for Families
This article explains what Alzheimer’s medications can and cannot do, so you can make informed decisions without false hope or unnecessary fear. These drugs are not cures, but they can modestly slow symptom progression or temporarily ease certain behaviors for some people. Understanding their real-world limits helps you focus on what truly matters: creating a safe, supportive environment and planning for the long journey ahead.
Key points
- Alzheimer’s medications are not cures; they modestly slow symptom progression or temporarily ease symptoms for some people.
- The two main types are acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine) for mild to moderate, and memantine for moderate to severe stages.
- New anti-amyloid drugs (lecanemab, donanemab) can slow decline by about 27% in early-stage patients but require infusions and MRI monitoring due to risk of brain swelling/bleeding.
- Non-drug approaches (calming routines, validation, redirection) should always be the first line for behavioral symptoms.
- Medications should be stopped in late-stage Alzheimer’s when the person is minimally responsive; a trial discontinuation is often recommended.
- Always review all current medications for anticholinergic effects that can worsen cognition.
The Two Main Families of Alzheimer’s Medications
There are two broad categories of FDA-approved Alzheimer’s drugs. The first are called acetylcholinesterase inhibitors (AChEIs), which include donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon). These work by slowing the breakdown of a brain chemical called acetylcholine, which is important for memory and thinking. In Alzheimer’s, the brain produces less acetylcholine, so these drugs try to keep what’s left around longer. They do not stop the underlying disease or repair damaged brain cells. They are considered moderately effective at best, and their benefit is often temporary—typically lasting months to a couple of years. The second category is memantine (Namenda), an NMDA receptor antagonist used for moderate to severe Alzheimer’s. It works by regulating another brain chemical, glutamate, to reduce over-excitation that can damage neurons. Memantine can be used alone or added to an AChEI. Neither type of drug cures Alzheimer’s or reverses its progression; they only help manage symptoms for a while.
The New Anti-Amyloid Drugs: A Different Kind of Hope—With Limits
In the last few years, two new drugs—lecanemab (Leqembi) and donanemab—have been approved for early-stage Alzheimer’s. These are called anti-amyloid antibodies because they target and remove amyloid plaques, a hallmark protein buildup in the Alzheimer’s brain. Clinical trials and early real-world data show they can modestly slow cognitive decline—about 27% over 18 months in one study—and reduce amyloid levels. However, they are not a cure. People on these drugs still decline; they just decline more slowly than those not on them. They are only appropriate for people in the very earliest stages of Alzheimer’s (mild cognitive impairment or mild dementia) and require regular intravenous infusions and MRI monitoring because they can cause brain swelling or micro-hemorrhages. These drugs are not for everyone, and they come with significant risks and costs. Discuss with your clinician whether your loved one is a candidate.
What Medications Do NOT Do: Managing Expectations
It is crucial to understand that no current Alzheimer’s medication—older or newer—can stop, reverse, or cure the disease. They do not repair damaged brain cells or address the underlying causes like amyloid plaques, tau tangles, or inflammation. They are purely symptomatic treatments. Many caregivers mistakenly believe that starting a medication will halt the disease’s progression, but the reality is that decline continues. The goal is to buy a little more time at a higher level of function. For people in later stages (very little speech, not walking, not recognizing others), experts agree these drugs likely provide no benefit and can be stopped. If stopping causes a noticeable worsening in agitation or confusion, it may be reasonable to restart, but this should be done under medical guidance.
General caregiving information, not medical advice. Check medications and major care changes with your clinician.
Step-by-step
Get a comprehensive evaluation with a neurologist or geriatrician who specializes in dementia, and bring every prescription, supplement, and over-the-counter drug so the doctor can flag anticholinergic medications (such as Benadryl, oxybutynin, and some antidepressants) that may be quietly worsening memory.
Ask which stage-specific medications apply: acetylcholinesterase inhibitors (donepezil, galantamine, or rivastigmine) for mild-to-moderate stages, memantine for moderate-to-severe stages, and anti-amyloid drugs (lecanemab or donanemab) only for early-stage patients who can commit to infusion schedules and regular MRI monitoring for brain swelling or micro-hemorrhages.
Start a simple symptom diary the day any new medication begins so you and the doctor can judge real benefit over 3-6 months, tracking memory, mood, agitation, sleep, and ability to handle daily tasks.
For agitation, paranoia, or hallucinations, lead with non-drug strategies—calm routines, validation, checking for pain or infection—and reserve antipsychotics for severe or dangerous cases, knowing they carry a black-box warning of increased stroke and death risk in older adults with dementia.
In late-stage disease, have an honest conversation with the doctor about whether continuing medications still helps; if stopping, taper slowly over several weeks and watch for rebound confusion or agitation.
What not to do
Don't expect a cure or dramatic turnaround; a medication that buys a few meaningful months—slightly longer conversations, fewer confused episodes, a gentler decline—is a real win worth celebrating.
Don't assume all memory changes are Alzheimer's without a medication review; common anticholinergic drugs are a reversible culprit that can mimic or worsen dementia symptoms.
Don't dismiss mild side effects as failure; nausea, loose stools, or mild dizziness often fade within a few weeks and can be managed with simple dose or schedule adjustments from your doctor.
Don't ignore red-flag side effects—severe nausea or vomiting, fainting, very slow heart rate, sudden headache with vision changes, or new confusion—call the doctor or go to the ER right away.
Practical tools
Daily Symptom Diary
A simple notebook or phone note with columns for date, mood (1-5 scale), notable memory moments, agitation episodes, sleep quality, and any new behaviors; bring it to every appointment so the clinician has concrete data to judge whether a medication is helping or causing problems.
Anticholinergic Medication Review Checklist
Before starting any Alzheimer's drug, ask the doctor to review every current medication, supplement, and OTC product and specifically flag anticholinergic ones—common offenders include diphenhydramine (Benadryl), oxybutynin (Ditropan), and tricyclic antidepressants—since reducing or stopping these can sometimes improve cognition as much as adding a new drug.
Non-Drug Behavior Toolkit
When agitation or paranoia flares, try phrases like 'I can see you're upset—let's sit down together with a cup of tea' or 'That must be frightening; I'm right here with you,' avoid arguing or correcting, and redirect to a calming activity such as folding towels, looking through a photo album, or listening to familiar music; these approaches often work better than medication and carry no side effects.
Doctor's Appointment Prep Sheet
Before each visit, write down three questions: 'Is my loved one still in the stage where these medications are likely to help?', 'What are the most common side effects, and what should I do if they occur?', and 'If we decide to stop a medication, what is the tapering plan?'; bring a notebook and take notes during the appointment.
Discuss with your clinician
Ask the doctor: 'Is my loved one a candidate for lecanemab or donanemab? What are the risks of brain swelling or bleeding, and how will we monitor for them?'
Ask: 'If we start an acetylcholinesterase inhibitor, what is the plan if side effects like nausea or slow heart rate occur?'
Ask: 'At what point would you recommend stopping these medications? What signs should I look for that indicate they are no longer helping?'
Ask: 'Are there any medications my loved one is currently taking that could be making their memory worse (anticholinergic drugs, benzodiazepines, sleep aids)?'
Ask: 'If we need to use a medication for severe agitation or psychosis, what are the risks, and what is the lowest effective dose we can try?'
Related guides
- Preparing for Caregiving by Understanding the Stages of Alzheimer's
- not taking sundowning personally
- Medication safety: spotting problems and checking OTCs
- Anticholinergic Alert: Why Common Medications Can Worsen Dementia & What to Do
- Living well with early-onset Alzheimer's
- Single-sensory care techniques for late-stage dementia
- Supporting meaningful risk-taking in Lewy body or Parkinson's dementia
- caregiver leadership and self-advocacy